Parenteral Drug Association Annex 1 – Revision of the EU GMP Guideline - Dublin, Ireland
: 17 May 2018
: Dublin, Ireland
Sector: Clinical, Pharmaceutical
The long-awaited draft of the revised Annex 1 has finally been released for discussion! The document’s content has increased significantly and the industry is eager to see which formerly missing subjects have now been included. Possible clarification on various vague topics is also highly anticipated.
A series of three conferences in Spain, Ireland and Germany will be set up by PDA Europe to cover the impact of these changes on the industry and on manufactures.
Local authorities as well as industry speakers will present their views on the revised Annex 1 and the modifications it induces.
The animated discussion arising will enable an extensive understanding of the new regulation.
For more information click here: www.pda.org